İpucu modu açıktır Kapat

SBIO - ALPS Medical Breakthroughs ETF (USD) (US00162Q5936)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Hepsini seç Hepsini sıfırla
 
(%)
US00162Q5936
SBIO ISIN
Borsa Yatırım Fonları (BYF)
Fon türü
ALPS Advisors
Sağlayıcı
53,41 USD
Hisse başına net varlık değeri | 02.04.2026
29.12.2014
Başlangıç ​​tarihi
1 yılda ... kez
Temettü ödemeleri
CEOJMS
CFI
SBIO
Menkul değer sembolü
Formed
Status
Equity
Yatırım kategorisi
Biotech
Sektör
USA
Coğrafya
S-Network Medical Breakthroughs Index
Karşılaştırma ölçütü (benchmark)
0.5 %
Toplam Maliyet Oranı
134,86 milyon USD
Fonun toplam varlıkları | 02.04.2026
134,86 milyon USD
Hisse senedi sınıfı varlıkları | 02.04.2026
Hayır
UCITS

Getiri on 02.04.2026, NYSE Arca

  • YTD
    6,64 %
  • 1M
    5,13 %
  • 3M
    6,64 %
  • 6M
    37,08 %
  • 1Y
    92,55 %
  • 3Y
    103,91 %
  • 5Y
    10,25 %
  • 10Y
    156,34 %
Gelir ödemeleri dikkate alınarak borsadaki fiyat üzerinden

Şu tarihe ilişkin son veriler
Karşılaştırmak için öğe ekleyin
başlangıç
bitiş
ADD-IN
Cbonds Eklentisi API
bond data api

Kotasyonlar (SBIO)

En kapsamlı veri tabanını keşfedin

1 000 000

tahvi̇ller

80 234

hisse senetleri

167 970

ETF & Funds

80 000

endeksler

Portföyünüzü en etkili şekilde takip edin

  • Tahvi̇l arama
  • Watchlist
  • Excel Eklentisi
Erişim sağlamak

Fiyat dinamiklerindeki değişimler

SBIO profile

The ALPS Medical Breakthroughs ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The ALPS Advisors fund’s base currency is USD and the share class was registered 29.12.2014 with unique ISIN - US00162Q5936. Main exchange is NYSE Arca and ticker symbol is SBIO. The total expense ratio is 0.5%. The ALPS Medical Breakthroughs ETF (USD) pays dividends 1 time(s) per year.

Yapı SBIO on 02.04.2026

Excel'de yapıyı indir
Menkul kıymet Değer
Kymera Therapeutics Inc. 4,21%
Alkermes PLC 3,5%
CG oncology Inc. 3,44%
Mirum Pharmaceuticals Inc. 3,43%
Celcuity Inc. 3,15%
Apellis Pharmaceuticals Inc. 3,12%
Apogee Therapeutics Inc. 2,85%
Xenon Pharmaceuticals Inc. 2,85%
Amicus Therapeutics Inc. 2,74%
Viking Therapeutics Inc. 2,43%
Crinetics Pharmaceuticals Inc. 2,35%
Dianthus Therapeutics Inc. 2,31%
Newamsterdam Pharma Co. NV 2,29%
Structure Therapeutics Inc. 2,29%
ACADIA Pharmaceuticals Inc. 2,28%
Spyre Therapeutics Inc. 2,26%
Edgewise Therapeutics Inc. 2,16%
Denali Therapeutics Inc. 1,98%
Tarsus Pharmaceuticals Inc. 1,8%
Vera Therapeutics Inc. 1,76%
Ideaya Biosciences Inc. 1,74%
Travere Therapeutics Inc. 1,7%
Oruka Therapeutics Inc. 1,56%
Disc Medicine Inc. 1,5%
Sarepta Therapeutics Inc. 1,47%
Zai Lab Ltd. 1,37%
Relay Therapeutics Inc. 1,35%
Day One Biopharmaceuticals Inc. 1,34%
Mineralys Therapeutics Inc. 1,29%
Tyra Biosciences Inc. 1,29%
Celldex Therapeutics Inc. 1,25%
Agios Pharmaceuticals Inc. 1,25%
Galapagos NV 1,17%
Stoke Therapeutics Inc. 1,13%
Pharvaris NV 1,1%
Sionna Therapeutics Inc. 1,1%
Vericel Corp. 1,05%
Palvella Therapeutics Inc. 1,02%
Amylyx Pharmaceuticals Inc. 1%
Rapport Therapeutics Inc. 0,97%
Immunocore Holdings PLC 0,94%
Nuvation Bio Inc. 0,92%
Oculis Holding AG 0,92%
MBX Biosciences Inc. 0,89%
Immatics NV 0,84%
Maze Therapeutics Inc. 0,83%
Bicara Therapeutics Inc. 0,82%
Novavax Inc. 0,76%
MoonLake Immunotherapeutics 0,75%
Corvus Pharmaceuticals Inc. 0,74%
Taysha Gene Therapies Inc. 0,72%
Olema Pharmaceuticals Inc. 0,72%
Zenas Biopharma Inc. 0,7%
ArriVent Biopharma Inc. 0,66%
Geron Corp. 0,64%
KalVista Pharmaceuticals Inc. 0,61%
Compass Therapeutics Inc. 0,59%
Xencor Inc. 0,57%
ARS Pharmaceuticals Inc. 0,5%
Theravance Biopharma Inc. 0,49%
MannKind Corp. 0,46%
Kura Oncology Inc. 0,46%
Design Therapeutics Inc. 0,42%
Alto Neuroscience Inc. 0,41%
Tectonic Therapeutic Inc. 0,35%
Fulgent Genetics Inc. 0,32%
Zura Bio Ltd. 0,31%
Upstream Bio Inc. 0,31%
Rigel Pharmaceuticals Inc. 0,31%
Aclaris Therapeutics Inc. 0,31%
Atea Pharmaceuticals Inc. 0,28%
REGENXBIO Inc. 0,27%
Altimmune Inc. 0,26%
Vanda Pharmaceuticals Inc. 0,25%
Akebia Therapeutics Inc. 0,22%
Candel Therapeutics Inc. 0,22%
Delcath Systems Inc. 0,2%
Forte Biosciences Inc. 0,19%
Neurogene Inc. 0,19%
Rezolute Inc. 0,18%
Anavex Life Sciences Corp. 0,17%
Protara Therapeutics Inc. 0,17%
Bicycle Therapeutics PLC 0,15%
Arcturus Therapeutics Holdings Inc. 0,14%
Aardvark Therapeutics Inc. 0,06%
Chinook Therapeutics Inc. 0%
AstraZeneca PLC 0%
Novo Nordisk A/S 0%
Cash Equivalent -0,07%
Tümünü göster Gizle
Other - %

Bu sağlayıcıdan diğer ETF ve Fonlar

Benzer ETF ve Fonlar

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} milyon
    Net Varlık Değeri
    {{ item.expense_ratio }}
    Toplam Maliyet Oranı
Kayıt gereklidir erişim için